
ACLU @ACLU
Patent-holders could control who can provide testing for genetic mutations associated with diseases like cancer, muscular dystrophy, Alzheimer’s disease, and heart disease, driving up prices for testing and jeopardizing patients. https://t.co/1APHAiiCgp — PolitiTweet.org